Luanda — The regional director for Africa of the World Health Organization (WHO), Luís Sambo, said Monday in Luanda that in the African region about 40 per cent of the population does not benefit from anti-retroviral treatment.
Luís Sambo, who was speaking at a press conference on the fringe of the 62nd regional session of the WHO/Africa, said that the lack of access to the mentioned medicine has brought about a world emergency that must be assessed with greater precision and consistency by the sector.
He informed that a strategy was analyzed for this situation, which is considering the possibility of some African countries to start or reinforcing the production of anti-retroviral medicine, aiming for the increase of supply and quality of product.
He explained that frequent migration can have serious consequences to health, considering the challenges many of them face in terms of discrimination, language, cultural barriers, legal and other socioeconomic situations.
On his turn, the Angolan Health minister defended that in the concrete case of Angola the limitations in the access to anti-retrovirus is not caused by financial issues, because in this country this medicine is free.
"In the framework of the programme for great endemic diseases, for the illnesses which affect the health more seriously (such as malaria, tuberculosis and HIV/Aids) the medicines are free (...)", he said.